Tirzepatide vs Semaglutide: Which GLP-1 Is Right for You in 2026?

Tirzepatide and semaglutide are both highly effective GLP-1 medications, but they differ in mechanism, efficacy, and side-effect profile. Here's a doctor's side-by-side comparison.

Majesta Health Medical TeamMedically Reviewed
Reviewed May 1, 20269 min read

The Short Answer

If you've been researching GLP-1 medications, you've probably noticed the two big names: tirzepatide (brand names Mounjaro and Zepbound) and semaglutide (Ozempic, Wegovy, and Rybelsus). They sound similar. They both help with weight loss. So which one is right for you?

Here's the honest answer in plain English:

  • Both work. Both are FDA-approved, both are prescribed by real doctors, and both have helped millions of people lose meaningful weight.
  • Tirzepatide tends to lead to more weight loss on average, about 20% of starting body weight over 72 weeks, compared to about 15% for semaglutide.
  • The right choice depends on you, your medical history, your budget, how you handle side effects, and what your doctor recommends.
  • This isn't a decision you have to make alone. A licensed physician will walk you through it. But if you want to understand what they'll be talking about, here's everything explained in normal human language.

    What These Medications Actually Do (in Plain English)

    Your body naturally makes a hormone called GLP-1 every time you eat a meal. Think of GLP-1 as your body's "I'm full" signal. It does three helpful things:

    1. Tells your stomach to slow down, so you stay full longer after meals 2. Tells your brain you're satisfied, so you stop thinking about food constantly (people on these meds often describe this as "the food noise quieting down") 3. Helps balance your blood sugar, so you don't get sudden hunger crashes

    For a lot of people, especially those who've struggled with weight for years, this signal doesn't work as well as it should. Hunger feels stronger. Cravings feel louder. Willpower runs out.

    GLP-1 medications give your body a stronger version of that natural signal. Once a week, you give yourself a small injection (it's much easier than it sounds). The medication works in the background, helping you eat less without constantly fighting yourself.

    Tirzepatide does something extra: it also taps into a second hormone called GIP. Activating both signals at once seems to be why tirzepatide tends to work a bit harder for most people.

    How Much Weight Can You Actually Lose?

    This is the question everyone wants answered. Here's what the largest clinical studies have found:

    On semaglutide (Wegovy): People lost about 15% of their starting body weight on average over 68 weeks. So someone starting at 250 lbs lost about 37 lbs on average.

    On tirzepatide (Zepbound): People lost about 20% of their starting body weight on average over 72 weeks. So someone starting at 250 lbs lost about 50 lbs on average.

    The honest caveat: "On average" hides a lot. Some people lose much more. Some people lose less. Your results depend on your starting weight, your eating habits, how active you are, and how well you tolerate the medication. The doctors at any reputable telehealth practice will tell you the same thing: the medication is a powerful tool, but it works best when you use it alongside small lifestyle changes, not as a replacement for them.

    Results vary. We can't and won't promise specific weight loss numbers, anyone who does is misleading you.

    What Side Effects Should You Expect?

    Let's be straightforward: most people on these medications experience some side effects, especially in the first month or two. The good news is they're usually manageable, and they tend to fade as your body adjusts.

    *The common ones (both medications):*

  • Nausea, the most common one. About 1 in 4 people on tirzepatide and a bit more on semaglutide.
  • Constipation or diarrhea (sometimes alternating)
  • Feeling tired during the first weeks
  • Heartburn or burping
  • Most of these come from the medication slowing down your digestion. Smaller meals, less fatty food, and good hydration usually solve them within a few weeks.

    *The rare but serious ones (both medications):*

  • Inflammation of the pancreas
  • Gallbladder issues (any rapid weight loss raises this risk, not just GLP-1s)
  • Severe dehydration from prolonged vomiting
  • Allergic reactions
  • And a special note: both medications carry an FDA warning about thyroid tumors based on animal studies. They are not safe for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. This is exactly the kind of question a real doctor will ask before prescribing, and one reason why these medications should never be bought without a proper medical consultation.

    For a much deeper look at side effects, we have a separate guide: Zepbound Side Effects: Complete Patient Guide.

    What About Cost?

    This is where things get real for most people. The brand-name versions are expensive without insurance:

  • Wegovy (semaglutide): about $1,350 per month
  • Zepbound (tirzepatide): about $1,090 per month
  • Mounjaro / Ozempic (used off-label for weight loss): $900–$1,200 per month
  • If you have insurance, your cost may be much lower, sometimes as little as $25 per month, depending on your plan.

    If you don't have coverage, there are still real options:

  • Lilly's Zepbound vials (a self-pay program): about $350–$500 per month
  • NovoCare savings card for Wegovy: up to $500 off per month if you have commercial insurance
  • Compounded semaglutide or tirzepatide through licensed telehealth pharmacies: starting at $179–$549 per month, depending on the medication and provider
  • For a full breakdown of the most affordable real options, see our cheapest GLP-1 telehealth guide.

    So Which One Is Right for You?

    Here's how doctors actually think about this choice. Neither one is "better", they're different tools for different situations.

    *Tirzepatide might be the better choice if you:*

  • Have a lot of weight to lose and want the most powerful option available
  • Have type 2 diabetes (it can help your blood sugar more)
  • Tried semaglutide first and didn't lose enough
  • Tolerate the early side effects reasonably well
  • *Semaglutide might be the better choice if you:*

  • Have heart disease or a history of stroke (semaglutide has FDA-approved heart-protection benefits)
  • Prefer a medication with a longer real-world track record
  • Want an oral pill option (Rybelsus is the only GLP-1 you can take by mouth)
  • Are looking for the most affordable starting point (compounded semaglutide is usually the cheapest real GLP-1 you can get safely)
  • The bottom line is simpler than you'd expect: the best GLP-1 medication is the one you can afford, tolerate, and stay on consistently. A lot of people start with semaglutide. Some switch to tirzepatide later if they want more progress. Some do well on the first one they try. There's no wrong starting place, just the place that works for you.

    How You Actually Get Started

    Getting GLP-1 treatment through a reputable telehealth provider is simpler than people expect. Here's what the process looks like with us at Majesta Health:

    1. A short health questionnaire, takes about 2 minutes. We ask about your medical history, current medications, and weight loss goals. 2. A real licensed physician reviews your file. Not an AI, not a form bot. A doctor licensed in your state. 3. They decide whether GLP-1 is right for you. If yes, they choose the medication and starting dose that fits your situation. If no, because of a contraindication or because something else might serve you better, they'll tell you that, too. 4. Your medication ships discreetly to your door, usually within 5–7 business days. 5. You can message your doctor anytime with questions, side effect concerns, or dose adjustments.

    That's it. No clinic visits, no waiting rooms, no awkward weigh-ins.

    Majesta Health is currently accepting founding members onto our waitlist. Joining now means priority access when we open, locked-in founding-member pricing, and a dedicated US-licensed physician overseeing your full journey, not a different one every time.


    Sources for the clinical data in this article: SURMOUNT-5 (New England Journal of Medicine, 2025), STEP 1 (NEJM, 2021), SURMOUNT-1 (NEJM, 2022), and FDA prescribing information for Wegovy and Zepbound. This article is for educational purposes only, it isn't medical advice. Always talk to a licensed physician before starting, stopping, or changing any medication. Results vary from person to person.

    Frequently Asked Questions

    Is tirzepatide more effective than semaglutide?

    In the head-to-head SURMOUNT-5 trial (NEJM, 2025), tirzepatide produced about 6.5% more body weight loss on average than semaglutide over 72 weeks (~20.2% vs ~13.7%). However, individual results vary, and tolerability often matters as much as average efficacy.

    Can I switch from semaglutide to tirzepatide?

    Yes, this is common and is determined case-by-case by your prescribing physician. The transition typically involves stopping semaglutide and restarting at a low tirzepatide dose (2.5 mg) with the standard titration schedule. Never switch medications without physician guidance.

    Do tirzepatide and semaglutide have the same side effects?

    The side-effect profiles overlap because both act on the GLP-1 receptor. The most common side effects, nausea, diarrhea, constipation, vomiting, occur with both. In head-to-head data, tirzepatide tends to cause slightly fewer GI side effects at comparable weight-loss doses.

    Which is cheaper, tirzepatide or semaglutide?

    Brand-name semaglutide (Wegovy) and tirzepatide (Zepbound) are similarly priced (around $1,000–$1,400/month without insurance). Compounded semaglutide is typically the most affordable option ($179–$399/month at telehealth providers).

    How long can I stay on a GLP-1 medication?

    GLP-1 medications are typically intended for long-term use, similar to medications for high blood pressure or cholesterol. Studies show that stopping the medication often results in regain of weight, so most patients continue with maintenance dosing under physician supervision.

    Ready to Reserve Your Spot?

    Join the founding-member waitlist for priority access and locked-in pricing.

    Join the Waitlist